An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies

Clinical trial NCT00226655 · COMPLETED

Trial details

NCT number: NCT00226655
Sponsor: Celtic Pharma Development Services
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Brain Edema Brain Tumor

Start date: 2005-07-01
Primary completion: 2009-03-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.